ID

43670

Beschreibung

Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention; ODM derived from: https://clinicaltrials.gov/show/NCT02273700

Link

https://clinicaltrials.gov/show/NCT02273700

Stichworte

Versionen (2)
  1. 25.04.16 25.04.16 -
  2. 20.09.21 20.09.21 -
Hochgeladen am

20. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Atrial Fibrillation NCT02273700

Englisch

Eligibility Atrial Fibrillation NCT02273700

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient was correctly informed about the study, its implementation, objectives, associated restrictions and patient rights
Beschreibung

Informing patient Study

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0588446
UMLS CUI [1,2]
C2603343
the patient must have given his/her informed and signed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
the patient must be insured or beneficiary of a health insurance plan
Beschreibung

health insurance plan

Datentyp

boolean

Alias
UMLS CUI [1]
C0679933
the patient is available for 1 month of follow-up
Beschreibung

Availability Follow-up

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C1522577
the patient has non-valvular atrial fibrillation that was diagnosed within the last 3 months. documentation of atrial fibrillation by a 12-lead ecg, an ecg rhythm strip, atrial fibrillation episode lasting at least 30 seconds.
Beschreibung

Atrial Fibrillation | 12 lead ECG | electrocardiogram rhythm strip | Episode of Atrial Fibrillation

Datentyp

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2]
C0430456
UMLS CUI [3]
C2022160
UMLS CUI [4,1]
C0332189
UMLS CUI [4,2]
C0004238
the patient has a cha2-ds2-vasc score = 1, that is to say the presence of at least one of the following risk factors: (1) congestive heart failure or moderate to severe systolic dysfunction of the left ventricle; (2) history of systolic blood pressure> 160 mmhg; (3) diabetes; (4) history of ischemic stroke or systemic embolism; (5) vascular disease (myocardial infarction, arterial disease); (6) age > 65 years; (7) female.
Beschreibung

Cerebrovascular accident Score | Congestive heart failure | Moderate left ventricular systolic dysfunction | Severe left ventricular systolic dysfunction | Systolic Pressure | Diabetes Mellitus | Ischemic stroke | EMBOLISM, SYSTEMIC ARTERIAL | Vascular Diseases | Myocardial Infarction | Arteriopathic disease | Age | Female

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0038454
UMLS CUI [1,2]
C0449820
UMLS CUI [2]
C0018802
UMLS CUI [3]
C3266752
UMLS CUI [4]
C3266753
UMLS CUI [5]
C0871470
UMLS CUI [6]
C0011849
UMLS CUI [7]
C0948008
UMLS CUI [8]
C0149876
UMLS CUI [9]
C0042373
UMLS CUI [10]
C0027051
UMLS CUI [11]
C0852949
UMLS CUI [12]
C0001779
UMLS CUI [13]
C0086287
the patient will start rivaroxaban (xarelto®) at the nîmes university hospital
Beschreibung

rivaroxaban Xarelto | Hospitals, University

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1739768
UMLS CUI [1,2]
C3159309
UMLS CUI [2]
C0020028
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient is participating in another interventional study
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
the patient has participated in another interventional study within the past three months
Beschreibung

Study Subject Participation Status Past

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1444637
the patient is in an exclusion period determined by a previous study
Beschreibung

Exclusion Criteria Period

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1948053
the patient is under judicial protection, under tutorship or curatorship
Beschreibung

judicial aspects

Datentyp

boolean

Alias
UMLS CUI [1]
C0243116
the patient refuses to sign the consent
Beschreibung

Unwilling Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0558080
UMLS CUI [1,2]
C0021430
it is impossible to correctly inform the patient
Beschreibung

Informing patient Unsuccessful

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0588446
UMLS CUI [1,2]
C1272705
the patient is pregnant, parturient, or breastfeeding
Beschreibung

Pregnancy | Parturition | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0005615
UMLS CUI [3]
C0006147
presence of a mechanical heart valve or valve disease
Beschreibung

HEART-VALVE, MECHANICAL | Heart valve disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0493527
UMLS CUI [2]
C0018824
patient who recieved another new direct oral anticoagulant other than xarelto® in the previous three months
Beschreibung

Other oral anticoagulants

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0354604
UMLS CUI [1,2]
C0205394
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Atrial Fibrillation NCT02273700

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informing patient Study
Item
the patient was correctly informed about the study, its implementation, objectives, associated restrictions and patient rights
boolean
C0588446 (UMLS CUI [1,1])
C2603343 (UMLS CUI [1,2])
Informed Consent
Item
the patient must have given his/her informed and signed consent
boolean
C0021430 (UMLS CUI [1])
health insurance plan
Item
the patient must be insured or beneficiary of a health insurance plan
boolean
C0679933 (UMLS CUI [1])
Availability Follow-up
Item
the patient is available for 1 month of follow-up
boolean
C0470187 (UMLS CUI [1,1])
C1522577 (UMLS CUI [1,2])
Atrial Fibrillation | 12 lead ECG | electrocardiogram rhythm strip | Episode of Atrial Fibrillation
Item
the patient has non-valvular atrial fibrillation that was diagnosed within the last 3 months. documentation of atrial fibrillation by a 12-lead ecg, an ecg rhythm strip, atrial fibrillation episode lasting at least 30 seconds.
boolean
C0004238 (UMLS CUI [1])
C0430456 (UMLS CUI [2])
C2022160 (UMLS CUI [3])
C0332189 (UMLS CUI [4,1])
C0004238 (UMLS CUI [4,2])
Cerebrovascular accident Score | Congestive heart failure | Moderate left ventricular systolic dysfunction | Severe left ventricular systolic dysfunction | Systolic Pressure | Diabetes Mellitus | Ischemic stroke | EMBOLISM, SYSTEMIC ARTERIAL | Vascular Diseases | Myocardial Infarction | Arteriopathic disease | Age | Female
Item
the patient has a cha2-ds2-vasc score = 1, that is to say the presence of at least one of the following risk factors: (1) congestive heart failure or moderate to severe systolic dysfunction of the left ventricle; (2) history of systolic blood pressure> 160 mmhg; (3) diabetes; (4) history of ischemic stroke or systemic embolism; (5) vascular disease (myocardial infarction, arterial disease); (6) age > 65 years; (7) female.
boolean
C0038454 (UMLS CUI [1,1])
C0449820 (UMLS CUI [1,2])
C0018802 (UMLS CUI [2])
C3266752 (UMLS CUI [3])
C3266753 (UMLS CUI [4])
C0871470 (UMLS CUI [5])
C0011849 (UMLS CUI [6])
C0948008 (UMLS CUI [7])
C0149876 (UMLS CUI [8])
C0042373 (UMLS CUI [9])
C0027051 (UMLS CUI [10])
C0852949 (UMLS CUI [11])
C0001779 (UMLS CUI [12])
C0086287 (UMLS CUI [13])
rivaroxaban Xarelto | Hospitals, University
Item
the patient will start rivaroxaban (xarelto®) at the nîmes university hospital
boolean
C1739768 (UMLS CUI [1,1])
C3159309 (UMLS CUI [1,2])
C0020028 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
the patient is participating in another interventional study
boolean
C2348568 (UMLS CUI [1])
Study Subject Participation Status Past
Item
the patient has participated in another interventional study within the past three months
boolean
C2348568 (UMLS CUI [1,1])
C1444637 (UMLS CUI [1,2])
Exclusion Criteria Period
Item
the patient is in an exclusion period determined by a previous study
boolean
C0680251 (UMLS CUI [1,1])
C1948053 (UMLS CUI [1,2])
judicial aspects
Item
the patient is under judicial protection, under tutorship or curatorship
boolean
C0243116 (UMLS CUI [1])
Unwilling Informed Consent
Item
the patient refuses to sign the consent
boolean
C0558080 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Informing patient Unsuccessful
Item
it is impossible to correctly inform the patient
boolean
C0588446 (UMLS CUI [1,1])
C1272705 (UMLS CUI [1,2])
Pregnancy | Parturition | Breast Feeding
Item
the patient is pregnant, parturient, or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0005615 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
HEART-VALVE, MECHANICAL | Heart valve disease
Item
presence of a mechanical heart valve or valve disease
boolean
C0493527 (UMLS CUI [1])
C0018824 (UMLS CUI [2])
Other oral anticoagulants
Item
patient who recieved another new direct oral anticoagulant other than xarelto® in the previous three months
boolean
C0354604 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video